Haider Mahdi, MD
Gynecologic Oncology fellow
Cleveland Clinic
9500 Euclid Avenue
Cleveland,
OH
USA
44195
Papers:
59
Does adjuvant pelvic radiation therapy improve survival in patients with uterine serous carcinoma who received adjuvant chemotherapy?
79
Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma
102
The impact of percent reduction in CA-125 levels on prediction of the extent of interval cytoreduction and outcome in patients with advanced stage cancer of müllerian origin treated with neoadjuvant chemotherapy
253
The impact of age on the risk of 30-day postoperative morbidity and mortality in patients undergoing surgery for ovarian cancer
265
Pathologic assessment of response to neoadjuvant chemotherapy in ovarian cancer: correlation with survival
363
Investigation of the timing of neoadjuvant chemotherapy on survival in advanced stage ovarian cancer
381
Molecular profile of uterine papillary serous carcinoma compared to ovarian serous carcinoma: is it the same disease at different site?
404
Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma
519
Biomarker comparison of epithelial ovarian cancer and endometrial cancer by multiplatform tumor profiling